Home/Filings/4/0001628280-24-013555
4//SEC Filing

Lee Sung 4

Accession 0001628280-24-013555

CIK 0001706431other

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 12:18 PM ET

Size

4.8 KB

Accession

0001628280-24-013555

Insider Transaction Report

Form 4
Period: 2024-03-27
Lee Sung
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2024-03-27$9.89/sh6,008$59,404100,492 total
Footnotes (1)
  • [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.

Issuer

Vir Biotechnology, Inc.

CIK 0001706431

Entity typeother

Related Parties

1
  • filerCIK 0001793200

Filing Metadata

Form type
4
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 12:18 PM ET
Size
4.8 KB